Valueclick (VCLK) estimates, target increased at UBS. VCLK estimates were raised through 2012. Acquisition should add to earnings. Neutral rating and new $16 price target.
Veeco Instruments (VECO) increased at UBS through 2012. Company is realizing higher orders. Buy rating and new $65 price target.
Watson Pharmaceuticals (WPI) estimates raised at Credit Suisse.
WPI 2011 and 2012 EPS estimates raised to $4.20 and $5.37, respectively. Solid volumes and pricing should drive better than expected 1Q results, Credit Suisse said. Maintain Outperform rating and $65 price target.
End of report.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV